Bitterroot Bio and Biotheus Announce Research Collaboration
Collaboration aims to discover novel bispecific proteins targeting immune modulators and inflammatory pathways implicated in cardiovascular disease...
Source: globenewswire.com
Pavan Cheruvu News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Pavan Cheruvu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Pavan Cheruvu Today - Breaking & Trending Today
Signs of Trouble Emerge as Sio Gene Halts UMass Gangliosidosis Deal
Sio Gene has terminated its licensing deal with the UMass to develop and commercialize two gene therapy product candidates to focus on more potentially profitable projects.
Source: biospace.com
Chutes & Ladders—Pfizer poaches Roche's early R&D leader Pao to replace development chief
Pfizer picks from Roche's executive team, snagging pharma early R&D leader William Pao as the Big Pharma's next chief development officer. Leo Pharma poaches from ... a Danish meme stock for its new CEO, who will lead a reorganization of the dermatology biopharma. And Sio Gene Therapies CEO Cheruvu is out the door as Parkinson's program also hits the exit.
Source: fiercebiotech.com
Oxford Biomedica Says Sio Gene Intends To End AXO-Lenti-PD License Deal
LONDON (dpa-AFX) - British gene and cell therapy company Oxford Biomedica Plc (OXB), said that Sio Gene Therapies has informed that it intends to return the global rights for AXO-Lenti-PD, a gene
Source: finanznachrichten.de
Chutes & Ladders—Athira CEO resigns after investigation confirms she altered research
Athira Pharma's CEO resigns after investigation confirms she altered research during graduate school. vTv Therapeutics named healthcare investor Deepa Prasad its new CEO and president. Opus Genetics snagged a new chief scientific officer and chief operating officer.
Source: fiercebiotech.com